Lost and Found: L2FU Recovers 100% of Clinical Trial Patients for Recent Pivotal Study

July 23, 2010

Company News Release

l

Lost to follow up (L2FU) patients who drop from a clinical trial and 'go missing' can impart a major set-back in pharmaceutical research.

L2FU, a company specializing in helping clinical trial sites and biopharma companies to locate, contact and collect data from patients deemed 'Lost to Follow-Up', is building a portfolio of successes and an industry reputation for its quality work. The L2FU team proudly reports its latest successful recovery of 100% of a recent study's lost clinical trial patients. This was achieved in only one month to meet a truncated timeline.  The client, a leading integrated managed care organization, with operations in a number of major states across the US and nearly 10 million patient members, required the information rapidly.L2FU is part of MediciGlobal.

Related Content:

News